{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:08:39Z","timestamp":1791328119356,"version":"4.3.1"},"reference-count":68,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,8,1]]},"DOI":"10.1210\/jcem.86.8.7753","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:07:29Z","timestamp":1389200849000},"page":"3826-3832","source":"Crossref","is-referenced-by-count":14,"title":["Mutational Analysis of the PRL Receptor Gene in Human Breast Tumors with Differential PRL Receptor Protein Expression"],"prefix":"10.1210","volume":"86","author":[{"given":"Annegret","family":"Glasow","sequence":"first","affiliation":[{"name":"Children\u2019s Hospital, University of Leipzig (A.G.), 04317 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-Christian","family":"Horn","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of Leipzig (L.-C.H.), 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Taymans","sequence":"additional","affiliation":[{"name":"Unit on Genetics and Endocrinology, Developmental Endocrinology Branch (S.E.T., C.A.S.), National Institute of Child Health and Human Development, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[{"name":"Unit on Genetics and Endocrinology, Developmental Endocrinology Branch (S.E.T., C.A.S.), National Institute of Child Health and Human Development, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Faculte\u0301 de Me\u0301dicine Necker, INSERM, U-344 (P.A.K.), 75730 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Kohler","sequence":"additional","affiliation":[{"name":"Hospital St. Georg (U.K.), 04129 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Gillespie","sequence":"additional","affiliation":[{"name":"of Pathology (J.G.), Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara K.","family":"Vonderhaar","sequence":"additional","affiliation":[{"name":"Laboratory of Tumor Immunology and Biology, Molecular and Cellular Endocrinology Section (B.K.V.), National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan R.","family":"Bornstein","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (S.R.B.), University of Duesseldorf, D-40225 Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041116322300100_R1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.47.1.5","article-title":"Cancer statistics, 1997.","volume":"47","author":"Parker","year":"1997","journal-title":"Ca Cancer J Clin"},{"key":"2019041116322300100_R2","first-page":"4","article-title":"Hormone alterations in breast cancer: examining the hypotheses.","volume":"4","author":"Hindle","year":"1999","journal-title":"Medscape Womens Health"},{"key":"2019041116322300100_R3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0378-5122(87)90061-2","article-title":"Endocrinology of breast cancer.","volume":"9","author":"Vorherr","year":"1987","journal-title":"Maturitas"},{"key":"2019041116322300100_R4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-3-642-79278-6_37","article-title":"International consensus conference on primary treatment of breast cancer.","volume":"140","author":"Goldhirsch","year":"1996","journal-title":"Recent Results Cancer Res"},{"key":"2019041116322300100_R5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1440-1622.1999.01515.x","article-title":"The genetic basis of breast cancer and its clinical implications.","volume":"69","author":"Bennett","year":"1999","journal-title":"Aust NZ J Surg"},{"key":"2019041116322300100_R6","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/jnci\/81.23.1780","article-title":"Mutations in human breast cancer: an overview.","volume":"81","author":"Callahan","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"2019041116322300100_R7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1182\/blood.V89.2.355","article-title":"Activating mutations in cytokine receptors: implications for receptor function and role in disease.","volume":"89","author":"Gonda","year":"1997","journal-title":"Blood"},{"key":"2019041116322300100_R8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0163-7258(98)00017-5","article-title":"Prolactin: the forgotten hormone of human breast cancer.","volume":"79","author":"Vonderhaar","year":"1998","journal-title":"Pharmacol Ther"},{"key":"2019041116322300100_R9","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1172\/JCI119820","article-title":"Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.","volume":"100","author":"Wennbo","year":"1997","journal-title":"J Clin Invest"},{"key":"2019041116322300100_R10","first-page":"951","article-title":"Prolactin and murine mammary tumorigenesis: a review.","volume":"37","author":"Welsch","year":"1977","journal-title":"Cancer Res"},{"key":"2019041116322300100_R11","first-page":"589","article-title":"Anti-growth action on mouse mammary and prostate glands of a monoclonal antibody to prolactin receptor.","volume":"133","author":"Sissom","year":"1988","journal-title":"Am J Pathol"},{"key":"2019041116322300100_R12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/edrv.19.3.0334","article-title":"Prolactin (PRL) and its receptor: actions, signal transducation pathways and phenotypes observed in PRL receptor knockout mice.","volume":"19","author":"Bole-Feysot","year":"1998","journal-title":"Endocr Rev"},{"key":"2019041116322300100_R13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0960-0760(90)90453-R","article-title":"Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer.","volume":"37","author":"Bonneterre","year":"1990","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041116322300100_R14","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1056\/NEJM198011203032130","article-title":"The epidemiology and etiology of breast cancer.","volume":"303","author":"Miller","year":"1980","journal-title":"N Engl J Med"},{"key":"2019041116322300100_R15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01806209","article-title":"Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells.","volume":"40","author":"Das","year":"1996","journal-title":"Breast Cancer Res Treat"},{"key":"2019041116322300100_R16","first-page":"411","article-title":"Cooperative and differential effects of estrogen, prolactin, 22K and 20K human growth hormones on cyclin D1\/PRAD1 gene expression in T-47D human breast cancer cells.","volume":"46","author":"Kaneko","year":"1998","journal-title":"Biochem Mol Biol Int"},{"key":"2019041116322300100_R17","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1210\/endo.140.11.7104","article-title":"Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin.","volume":"140","author":"Coss","year":"1999","journal-title":"Endocrinology"},{"key":"2019041116322300100_R18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3181\/00379727-202-43545","article-title":"Glucocorticoid-prolactin interactions in Nb2 lymphoma cells: antiproliferative versus anticytolytic effects [published erratum appears in Proc Soc Exp Biol Med 1993 Jun;203(2):260].","volume":"202","author":"Fletcher-Chiappini","year":"1993","journal-title":"Proc Soc Exp Biol Med"},{"key":"2019041116322300100_R19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/ije\/21.2.214","article-title":"Relationship of blood prolactin levels and the risk of subsequent breast cancer.","volume":"21","author":"Wang","year":"1992","journal-title":"Int J Epidemiol"},{"key":"2019041116322300100_R20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ijc.2910340307","article-title":"Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer.","volume":"34","author":"Holtkamp","year":"1984","journal-title":"Int J Cancer"},{"key":"2019041116322300100_R21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5694\/j.1326-5377.1990.tb126153.x","article-title":"Prolactin and breast cancer risk.","volume":"153","author":"Ingram","year":"1990","journal-title":"Med J Aust"},{"key":"2019041116322300100_R22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/(SICI)1096-9098(199606)62:2<86::AID-JSO3>3.0.CO;2-M","article-title":"Node negative breast carcinoma: hyperprolactinemia and\/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators.","volume":"62","author":"Patel","year":"1996","journal-title":"J Surg Oncol"},{"key":"2019041116322300100_R23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/jnci\/91.7.629","article-title":"Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women.","volume":"91","author":"Hankinson","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2019041116322300100_R24","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1210\/endo.138.12.5605","article-title":"Expression of prolactin and its receptor in human breast carcinoma.","volume":"138","author":"Reynolds","year":"1997","journal-title":"Endocrinology"},{"key":"2019041116322300100_R25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jcem.83.2.4564","article-title":"Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues.","volume":"83","author":"Touraine","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116322300100_R26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/(SICI)1097-0215(19980417)79:2<202::AID-IJC17>3.0.CO;2-B","article-title":"Cellular expression of growth hormone and prolactin receptors in human breast disorders.","volume":"79","author":"Mertani","year":"1998","journal-title":"Int J Cancer"},{"key":"2019041116322300100_R27","first-page":"120","article-title":"Prolaktin und seine Bedeutung fu\u0308r die Frau","author":"Bohnet","year":"1981","journal-title":"In: Schirren C, Semm K, eds. Prolaktin und seine Bedeutung fu\u0308r die Frau, FDF 9. Berlin: Grosse;"},{"key":"2019041116322300100_R28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01806263","article-title":"Prolactin binding by human mammary carcinoma: relationship to estrogen receptor protein concentration and patient age.","volume":"1","author":"Rae-Venter","year":"1981","journal-title":"Breast Cancer Res Treat"},{"key":"2019041116322300100_R29","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/bjc.1995.162","article-title":"Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts.","volume":"71","author":"Watson","year":"1995","journal-title":"Br J Cancer"},{"key":"2019041116322300100_R30","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.1074\/jbc.274.15.10024","article-title":"Constitutive activation of the prolactin receptor results in the induction of growth factor-independent proliferation and constitutive activation of signaling molecules.","volume":"274","author":"Lee","year":"1999","journal-title":"J Biol Chem"},{"key":"2019041116322300100_R31"},{"key":"2019041116322300100_R32","first-page":"4459","article-title":"Expression of Ob receptor in normal human adrenals: differential regulation of adrenocortical and adrenomedullary function by leptin.","volume":"83","author":"Glasow","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116322300100_R33","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ijc.2910550503","article-title":"Characterization of a monoclonal antibody against human prolactin receptors.","volume":"55","author":"Banerjee","year":"1993","journal-title":"Int J Cancer"},{"key":"2019041116322300100_R34","first-page":"138","article-title":"Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue.","volume":"8","author":"Remmele","year":"1987","journal-title":"Pathologe"},{"key":"2019041116322300100_R35","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1126\/science.274.5289.998","article-title":"Laser capture microdissection.","volume":"274","author":"Emmert-Buck","year":"1996","journal-title":"Science"},{"key":"2019041116322300100_R36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3109\/07435809809032697","article-title":"Differential expression of prolactin receptor (PRLR) in normal and tumorous adrenal tissues: separation of cellular endocrine compartments by laser capture microdissection (LCM).","volume":"24","author":"Glasow","year":"1998","journal-title":"Endocr Res"},{"key":"2019041116322300100_R37","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.278.5342.1481","article-title":"Laser capture microdissection: molecular analysis of tissue.","volume":"278","author":"Bonner","year":"1997","journal-title":"Science"},{"key":"2019041116322300100_R38","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1210\/jcem.84.3.5659","article-title":"The human prolactin receptor gene structure and alternative promoter utilization: the generic promoter hPIII and a novel human promoter hP(N).","volume":"84","author":"Hu","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116322300100_R39","first-page":"72","article-title":"Large-scale preparation of sequence-ready bacterial artificial chromosome DNA using QIAGEN columns.","volume":"27","author":"Kirschner","year":"1999","journal-title":"BioTechniques"},{"key":"2019041116322300100_R40","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1210\/mend-3-9-1455","article-title":"Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells.","volume":"3","author":"Boutin","year":"1989","journal-title":"Mol Endocrinol"},{"key":"2019041116322300100_R41","first-page":"1035","article-title":"Highly specific sites of prolactin binding in benign and malignant breast tissue.","volume":"27","author":"Agarwal","year":"1989","journal-title":"Indian J Exp Biol"},{"key":"2019041116322300100_R42","first-page":"192","article-title":"Immunocytochemical analysis of human prolactin receptors using anti-idiotypic antibodies in human breast cancer.","volume":"15","author":"Leroy-Martin","year":"1995","journal-title":"Ann Pathol"},{"key":"2019041116322300100_R43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(197902)43:2<643::AID-CNCR2820430235>3.0.CO;2-C","article-title":"Prolactin receptors in human breast carcinoma.","volume":"43","author":"Partridge","year":"1979","journal-title":"Cancer"},{"key":"2019041116322300100_R44","first-page":"1946","article-title":"Hormone binding by human mammary carcinoma.","volume":"37","author":"Holdaway","year":"1977","journal-title":"Cancer Res"},{"key":"2019041116322300100_R45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF02820507","article-title":"Progesterone-dependent decidualization of the human endometrium is mediated by camp.","volume":"6","author":"Brar","year":"1997","journal-title":"Endocrine"},{"key":"2019041116322300100_R46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ijc.2910310407","article-title":"The localization of prolactin binding sites in human breast tissue.","volume":"31","author":"Dhadly","year":"1983","journal-title":"Int J Cancer"},{"key":"2019041116322300100_R47","doi-asserted-by":"crossref","first-page":"35461","DOI":"10.1074\/jbc.274.50.35461","article-title":"Functional characterization of the intermediate isoform of the human prolactin receptor.","volume":"247","author":"Kline","year":"1999","journal-title":"J Biol Chem"},{"key":"2019041116322300100_R48","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1242\/jcs.110.9.1123","article-title":"Internalization of prolactin receptor and prolactin in transfected cells does not involve nuclear translocation.","volume":"110","author":"Perrot-Applanat","year":"1997","journal-title":"J Cell Sci"},{"key":"2019041116322300100_R49","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0277-5379(82)90097-9","article-title":"Prolactin receptors in human breast cancer.","volume":"18","author":"Bonneterre","year":"1982","journal-title":"Eur J Cancer Clin Oncol"},{"key":"2019041116322300100_R50","first-page":"3692","article-title":"Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer.","volume":"82","author":"Ormandy","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116322300100_R51","first-page":"31317","volume":"273","author":"Richer","year":"1998"},{"key":"2019041116322300100_R52","first-page":"1963","article-title":"Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.","volume":"44","author":"Murphy","year":"1984","journal-title":"Cancer Res"},{"key":"2019041116322300100_R53","first-page":"327","article-title":"Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer.","volume":"42","author":"Ben-David","year":"1988","journal-title":"Biomed Pharmacother"},{"key":"2019041116322300100_R54","first-page":"517","article-title":"Prognostic value of estrogen and prolactin receptor analysis in human breast cancer","volume":"76","author":"Waseda","year":"1985","journal-title":"Jpn J. Cancer Res"},{"key":"2019041116322300100_R55","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/bjc.1990.346","article-title":"Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study.","volume":"62","author":"De Placido","year":"1990","journal-title":"Br J Cancer"},{"key":"2019041116322300100_R56","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1016\/0303-7207(93)90247-H","article-title":"Mechanisms of prolactin receptor regulation in mammary gland","volume":"91","author":"Ormandy","year":"1993","journal-title":"Mol Cell Endocrinol"},{"key":"2019041116322300100_R57","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0022-4731(87)90394-3","article-title":"Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancer.","volume":"28","author":"Mobbs","year":"1987","journal-title":"J Steroid Biochem"},{"issue":"Suppl A","key":"2019041116322300100_R58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1096-6374(99)80011-2","article-title":"Defects of the growth hormone receptor and their clinical implications","volume":"9","author":"Savage","year":"1999","journal-title":"Growth Horm IGF Res"},{"issue":"Suppl","key":"2019041116322300100_R59","first-page":"127","article-title":"Molecular biology of growth hormone receptor dysfunction","volume":"383","author":"Phillips","year":"1992","journal-title":"Acta Paediatr"},{"key":"2019041116322300100_R60","first-page":"347","article-title":"Diagnostik und Therapie von malignen Tumoren und deren Vorstadien an der Mamma","author":"Bender","year":"1991","journal-title":"In: Bender HG, ed. Gynaekologische Onkologie. Stuttgart: Georg Thieme Verlag;"},{"key":"2019041116322300100_R61","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/bbrc.1999.0602","article-title":"Prolactin-dependent Up-regulation of BRCA1 expression in human breast cancer cell lines.","volume":"258","author":"Favy","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041116322300100_R62","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12\u201313.","volume":"265","author":"Wooster","year":"1994","journal-title":"Science"},{"key":"2019041116322300100_R63","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng0396-333","article-title":"The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.","volume":"12","author":"Tavtigian","year":"1996","journal-title":"Nat Genet"},{"key":"2019041116322300100_R64","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1210\/jcem-58-5-826","article-title":"Demonstration of biological activity of prolactin molecular weight variants in human sera.","volume":"58","author":"Whitaker","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116322300100_R65","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1210\/endo-124-3-1558","article-title":"Two forms of glycosylated human prolactin have different pigeon crop sac-stimulating activities.","volume":"124","author":"Lewis","year":"1989","journal-title":"Endocrinology"},{"key":"2019041116322300100_R66","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/BF03348932","article-title":"Glycosylation of human prolactin regulates hormone bioactivity and metabolic clearance.","volume":"16","author":"Hoffmann","year":"1993","journal-title":"J Endocrinol Invest"},{"key":"2019041116322300100_R67","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0024-3205(98)00389-0","article-title":"Phosphorylation of bovine prolactin eliminates luteotropic activity in the rat.","volume":"63","author":"Brooks","year":"1998","journal-title":"Life Sci"},{"key":"2019041116322300100_R68","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0303-7207(99)00023-4","article-title":"Should prolactin be reconsidered as a therapeutic target in human breast cancer?","volume":"151","author":"Goffin","year":"1999","journal-title":"Mol Cell Endocrinol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/86\/8\/3826\/9168050\/jcem3826.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:12:07Z","timestamp":1647907927000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/86\/8\/3826\/2848975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,1]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.86.8.7753","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8,1]]}}}